Esophageal Balloon Guided Weaning of the Morbidly Obese Patient

Sponsor
East Carolina University (Other)
Overall Status
Terminated
CT.gov ID
NCT02323009
Collaborator
(none)
25
1
3
34
0.7

Study Details

Study Description

Brief Summary

This is a study to evaluate whether PEEP adjusted by use of an esophageal balloon to overcome negative transpulmonary pressure; or adjusted by use of "CStat" to achieve the best effective static compliance will have any effect on outcomes with respect to ventilator weaning in tracheotomized morbidly obese patients (BMI >=40) with at least one failed prior weaning attempt.

Condition or Disease Intervention/Treatment Phase
  • Device: Esophageal Balloon
  • Other: Cstat
N/A

Detailed Description

Tracheotomized morbidly obese patients (BMI >= 40) who had failed an initial attempt at ventilator weaning (defined in the investigators study as ventilator dependent) were randomly assigned to one of two methods for setting Positive End Expiratory Pressure (PEEP).

Patients randomized to the esophageal balloon arm (ESO group) had their PEEP adjusted to overcome negative transpulmonary pressure and maintain a positive transpulmonary pressure (Ptp) of 0 to 10 cm H20 - targeting as close to zero as possible.

Patients randomized to the static effective compliance arm (CStat group) had their PEEP adjusted to achieve the best static effective compliance as automatically calculated and displayed on the graphic interphase of the hamilton G5 or Galileo ventilator. For this group, the PEEP was adjusted in increments of 3 cm H20 until there was a less than 5% observed improvement in the static effective compliance. the PEEP with the best Cstat was chosen.

At the end of the intervention period, this intervention cohort (termed "PEEP intervention cohort") will be compared to a group of historical controls to compare the efficiency of a PEEP-based weaning protocol to traditional weaning methods.

The investigators hypothesized that PEEP levels titrated by use of an esophageal balloon to maintain a positive transpulmonary pressure between 0 to 10 cm H20, would lead to improved outcomes with respect to ventilator weaning in this subset of patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Esophageal Balloon Guided Weaning of the Morbidly Obese Patient
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Nov 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Esophageal balloon Arm

Patients in this arm were randomly assigned to have their PEEP adjusted to maintain a positive transpulmonary pressure (0 to 10 cm H20).

Device: Esophageal Balloon
Esophageal balloon was used to measure esophageal pressure (Paux) which was used as an estimate of pleural pressure. Transpulmonary pressure (Ptp) was calculated as the difference between airway pressure (Pao) and Paux. Applied PEEP was then adjusted to overcome negative Ptp which we maintained between 0 to 10 cm H20. All measurements were made at end-expiration.

Active Comparator: Cstat Arm

Patients in this arm had their PEEP adjusted to achieve the best static effective compliance (CStat).

Other: Cstat
PEEP was adjusted to achieve the best CStat in this group of patients

No Intervention: Historic Controls

These were historic controls with similar patient characteristics weaned by traditional methods in the 2-year period prior to the start of the study.

Outcome Measures

Primary Outcome Measures

  1. Number of patients weaned by day 30 [30-days]

    A patient was considered successfully weaned and "ventilator independent" if they were spontaneously breathing without ventilator support for at least 24 hours, and remained off the ventilator by day 30. If ventilator support was subsequently required, the patient was returned to their original group and considered not weaned. The patients were considered to be weaned or not, after a period of thirty days.

Secondary Outcome Measures

  1. Time to wean [30-days]

    The time to wean/ time to achieve ventilator independence was measured from the date of randomization to the date of final successful liberation from mechanical ventilation. If patient had an unsuccessful initial wean, he was not considered weaned. Only patients who were considered weaned by day 30 accrued "time to ventilator independence."

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Morbidly obese patients with BMI of 40 or greater

  • Ventilator dependent patients (defined as at least one prior failure at weaning)

  • Tracheotomized

  • No active underlying lung disease that would preclude ventilator weaning

  • Stable hemodynamics

  • Patient/ family able to give consent

  • No naso-facial abnormalities that would interfere with placement of an esophageal balloon

  • Fio2 <= 60%

  • Patient able to tolerate Pressure Support ventilation

Exclusion Criteria:
  • Lack of consent

  • Patient deemed not weanable from mechanical ventilation as per the clinical judgement of the pulmonary physician

  • Significant lung, heart or neuromuscular disease that would interfere with or preclude ventilator weaning, including an active ongoing lung infection.

  • Contraindications to placement of an esophageal pressure monitoring device - such as ulcerations, tumors, diverticulitis, uncontrolled bleeding varices, sinusitis, epistaxis or recent nasopharyngeal surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vidant Medical Center Greenville North Carolina United States 27834

Sponsors and Collaborators

  • East Carolina University

Investigators

  • Principal Investigator: Robert Shaw, MD, East Carolina University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ogugua N Obi, MD, MPH, Robert Shaw, MD (Principal Investigator), East Carolina University
ClinicalTrials.gov Identifier:
NCT02323009
Other Study ID Numbers:
  • Protocol 10-0343
First Posted:
Dec 23, 2014
Last Update Posted:
Dec 23, 2014
Last Verified:
Dec 1, 2014
Keywords provided by Ogugua N Obi, MD, MPH, Robert Shaw, MD (Principal Investigator), East Carolina University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 23, 2014